ChemoCentryx, Inc. Assets, Fair Value Disclosure
ChemoCentryx, Inc. had Assets, Fair Value Disclosure of $122.44 million as of 2014-09-30, per its 10-Q filed 2014-11-06.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2014-11-06
- 2014-09-30: Assets, Fair Value Disclosure $122.44M.
- 2014-06-30: Assets, Fair Value Disclosure $131.38M.
- 2014-03-31: Assets, Fair Value Disclosure $140.32M.
- 2013-12-31: Assets, Fair Value Disclosure $147.83M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2014-09-30 | $122.44M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $131.38M 10-Q · filed 2014-08-08 |
| 2014-03-31 | $140.32M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $147.83M 10-Q · filed 2014-11-06 |
| 2013-09-30 | $156.28M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $164.24M 10-Q · filed 2013-08-13 |
| 2013-03-31 | $108.16M 10-Q · filed 2013-05-14 |
| 2012-12-31 | $117.56M 10-K · filed 2014-03-14 |
| 2012-09-30 | $127.52M 10-Q · filed 2012-11-13 |
| 2012-06-30 | $135.34M 10-Q · filed 2012-08-10 |
| 2011-12-31 | $95.34M 10-K · filed 2013-03-14 |